<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A high level of gastric acid secretion is considered to be a risk factor for <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> or <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> may have a protective effect on the oesophagus, because of decreased gastric acid output </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To determine if corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> is associated with <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> or <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Three antral and two corpus biopsies were taken from consecutive patients in whom Helicobacter pylori testing was requested during endoscopy at a single centre between January 1995 and May 1997 </plain></SENT>
<SENT sid="4" pm="."><plain>Antral and corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> was studied by histology; H. pylori was studied by histology, culture and CLO test </plain></SENT>
<SENT sid="5" pm="."><plain>A regression model was used to test for correlation between <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e>, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and risk factors </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: During the study period, 676 patients had biopsies taken during upper gastrointestinal endoscopy </plain></SENT>
<SENT sid="7" pm="."><plain>Endoscopic signs of <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were observed in 125 and 23 patients, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> was found in 59% of patients without <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> or <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, 45% of patients with <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> and 30% of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Two hundred and fifty-seven patients underwent follow-up endoscopy after H. pylori therapy </plain></SENT>
<SENT sid="10" pm="."><plain>During a mean follow-up of 3 months, the incidence of <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> was not statistically different for patients with healing of corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> (10/98; 10%) and patients with persistent <z:hpo ids='HP_0005263'>gastritis</z:hpo> (8/97; 8%) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Corpus <z:hpo ids='HP_0005263'>gastritis</z:hpo> was less common in patients with an endoscopic diagnosis of <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> or <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
</text></document>